Mental Disorders

Autism Subtypes Show Distinct Brain Connectivity Patterns Along the Sensorimotor–Association Axis

Children and adults with autism exhibit altered large-scale brain connectivity patterns compared with typically developing individuals, and these differences are most pronounced in a subtype characterized by lower language, intellectual, and adaptive functioning (LIAF). Using data-driven clustering of standardized phenotypic measures from 419 individuals in the US National Institute of Mental Health Data Archive, researchers identified two distinct autism subtypes—high and low LIAF—that generalized to independent datasets with 92% accuracy. The subtype model was then applied to resting-state fMRI data from 174 individuals with autism and 185 typically developing controls. Overall, autism was associated with increased functional connectivity in higher-order association regions and reduced connectivity in sensorimotor regions. These connectivity differences were especially evident in the low-LIAF autism subgroup and followed the brain’s sensorimotor–association (S-A) axis, a key organizational gradient of neurodevelopment. The findings suggest that atypical cortical patterning along the S-A axis persists beyond early childhood and may be particularly pronounced in individuals with autism who have greater challenges in language, intellectual, and adaptive functioning. Source: https://www.sciencedirect.com/

hyangiu

Recent Posts

Intensive BP Control Reduces Cardiovascular Events After Ischemic Stroke

Targeting a systolic blood pressure (BP) of less than 120 mm Hg lowered the incidence…

20 hours ago

No Significant Reduction in Major Cardiovascular Events with Intensive BP Lowering in T2D

In patients with type 2 diabetes (T2D) and high cardiovascular risk, targeting a systolic blood…

20 hours ago

Stopping Statins Noninferior to Continuing Them in Older Adults without Known CVD

Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing…

22 hours ago

Ziltivekimab and Pelacarsen Show No Clinical Benefit Despite Effective Biomarker Lowering

Two randomized, placebo-controlled trials of targeted therapies—ziltivekimab, a monoclonal antibody neutralizing interleukin-6, and pelacarsen, an…

2 days ago

Cold Drives Heart Failure Hospitalizations in Older US Adults

Among US Medicare beneficiaries, colder ambient temperatures were associated with increased heart failure hospitalizations while…

6 days ago

No Significant Difference Between Initial CTO-PCI and No CTO-PCI Strategies in 10-Year Follow-Up

In the 10-year extended follow-up of the DECISION-CTO trial, an initial strategy of percutaneous coronary…

6 days ago

This website uses cookies.